Cleared Traditional

BPROSOFT CASP PC SOFTWARE (K131916) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K131916 · Healthstats International Pte. , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
258d
Days
Class 2
Risk

K131916 is an FDA 510(k) clearance for the BPROSOFT CASP PC SOFTWARE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Healthstats International Pte. , Ltd. (Eagle, US). The FDA issued a Cleared decision on March 11, 2014 after a review of 258 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Healthstats International Pte. , Ltd. devices

Submission Details

510(k) Number K131916 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 2013
Decision Date March 11, 2014
Days to Decision 258 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
133d slower than avg
Panel avg: 125d · This submission: 258d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 293
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K131916.
Fully Automatic Electronic Blood Pressure Monitor
K151460 · Andon Health Co, Ltd. · Sep 2015
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K141984 · Andon Health Co, Ltd. · Apr 2015
EV1000 CLINICAL PLATFORM WITH CLEARSIGHT TM FINGER CUFF OR CLEARSIGHT TM SYSTEM
K140312 · Edwards Lifesciences, LLC · Jun 2014
NEXFIN MODEL 2
K122381 · Edwards Lifesciences, LLC · Apr 2013
U-RIGHT TD-3124 BLOOD PRESSURE MONITORING SYSTEM
K120634 · Taidoc Technology Corporation · Jul 2012
SURESIGNS VS3 VITAL SIGNS MONITOR, SURESIGNS VS4 VITAL SIGNS MONITOR
K120132 · Philips Medical Systems · Feb 2012